- Home
- PARK vs NRXS Comparison
PARK vs NRXS Comparison
Compare PARK & NRXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PARK | NRXS |
|---|---|---|
| Founded | 1972 | 2011 |
| Country | United States | United States |
| Employees | 1212 | N/A |
| Industry | Misc Health and Biotechnology Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.9M | 78.9M |
| IPO Year | N/A | 2023 |
Fundamental Metrics
Financial Performance| Metric | PARK | NRXS |
|---|---|---|
| Price | $18.12 | $6.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 21.8K | ★ 117.0K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 22.13 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,569,282.00 |
| Revenue This Year | $7.06 | $172.91 |
| Revenue Next Year | $6.17 | $115.71 |
| P/E Ratio | $6.47 | ★ N/A |
| Revenue Growth | N/A | ★ 32.89 |
| 52 Week Low | $12.29 | $2.20 |
| 52 Week High | $22.62 | $9.33 |
Technical Indicators
Market Signals| Indicator | PARK | NRXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.20 | 44.48 |
| Support Level | $17.33 | $6.24 |
| Resistance Level | $19.14 | $7.79 |
| Average True Range (ATR) | 1.41 | 0.43 |
| MACD | -0.19 | -0.03 |
| Stochastic Oscillator | 10.45 | 38.93 |
Price Performance
Historical ComparisonAbout PARK Park Dental Partners Inc.
Park Dental Partners Inc is a dental resource organization (DRO) operating through its subsidiary. It Provides comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to its affiliated general and multi-specialty dental practices throughout Minnesota and Wisconsin. Its network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30-years, with automatic 5-year renewals.
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).